Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Altimmune’s Pemvidutide Garners Mixed Reviews Following Phase II Obesity Data
Stock Down By 55%
Mar 22 2023
•
By
Ayisha Sharma
Pemvidutide Was Combined With Diet And Exercise Measures • Source: Shutterstock
More from Clinical Trials
More from R&D